Gea Pharma Systems Limited
Company profile
DissolvedUnited Kingdom
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2024-12-31
IXBRL · 29 source facts · 4 selected values
Validation findingsXBRL valid
Accounts to 2024-12-31
IXBRL · 29 source facts · 4 selected values
Validation findings
XBRL valid
- Reporting period
- 2024-01-01 to 2024-12-31
- Extraction status
- complete
- Numeric facts
- 8
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2503_00930232_20241231
- Source archive
- Accounts_Monthly_Data-March2025.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2023-12-31
IXBRL · 29 source facts · 4 selected values
Not assessedlegacy record
Accounts to 2023-12-31
IXBRL · 29 source facts · 4 selected values
Not assessed
legacy record
- Reporting period
- 2023-01-01 to 2023-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 8
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_1966_00930232_20231231
- Source archive
- Accounts_Monthly_Data-April2024.zip
Registered details
00930232- Status
- Dissolved
- Type
- Unknown
- Incorporated
- —
- Jurisdiction
- —
- Registered office
- —
Classification
0 SIC codesNo SIC classification available.
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
4 matched grantsEHDA Network-Pharmaceutical EHDA Technology: Developing QbD Facilitated, Continuous and Scaled Therapy Enabling PlatformsEPSRC · Research Grant · 2015-10-30 – 2017-10-28 · with 31 other participants£169,320whole project
EHDA Network-Pharmaceutical EHDA Technology: Developing QbD Facilitated, Continuous and Scaled Therapy Enabling Platforms
EPSRC · Research Grant · 2015-10-30 – 2017-10-28 · with 31 other participants
£169,320
whole project
De Montfort UniversityleadAristotle University of ThessalonikiAshlandAshland Composite PolymersBlueFrog DesignCardiff UniversityElvesysGEA Pharma Systems LtdGenVolt LtdGskImperial College LondonKing Juan Carlos UniversityLoughborough UniversityOncoLytikaRotronic Measurment SolutionSympatecUmetricsUmetrics MKS ABUniversity College LondonUniversity Of BathUniversity Of BirminghamUniversity Of NottinghamUniversity of PortsmouthUniversity Of PortsmouthUniversity of SheffieldUniversity of SunderlandUniversity Of SunderlandUniversity of SurreyUniversity Of SussexUniversity of TwenteVolitionRXZhejiang University
Advance Secondary Pharmaceutical ManufacturingInnovate UK · Collaborative R&D · 2009-10-01 – 2012-03-31 · with 5 other participants£500,000awarded
Advance Secondary Pharmaceutical Manufacturing
Innovate UK · Collaborative R&D · 2009-10-01 – 2012-03-31 · with 5 other participants
£500,000
awarded
GEA Pharma Systems Limited£500,000
University of Newcastle£220,753
LyoDEA: In-process sensing technology for control of the freeze-drying cycleLeadInnovate UK · Collaborative R&D · 2008-11-01 – 2012-10-31 · with 3 other participants£23,507awarded
LyoDEA: In-process sensing technology for control of the freeze-drying cycleLead
Innovate UK · Collaborative R&D · 2008-11-01 – 2012-10-31 · with 3 other participants
£23,507
awarded
De Montfort University£176,459
GEA Pharma Systems Limitedlead£23,507
Minimising the Environmental Footprint of FMCG Plant: Improved Cleaning ProcessesInnovate UK · Feasibility Studies · 2006-10-01 – 2010-12-31 · with 10 other participants£0awarded
Minimising the Environmental Footprint of FMCG Plant: Improved Cleaning Processes
Innovate UK · Feasibility Studies · 2006-10-01 – 2010-12-31 · with 10 other participants
£0
awarded
University of Newcastle£482,193
GEA Pharma Systems Limited£0